SCHEMBL20749862

SCHEMBL20749862

CN/C1=C(\C)CCCCCC1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17199405 1.00 CYP1A2 (0.31) CYP1A2POLBGAA
SCHEMBL25919081 0.97
SCHEMBL5703437 0.80
SCHEMBL10037076 0.79
SCHEMBL609517 0.78 CYP1A2 (0.32) CYP1A2POLBGAA
SCHEMBL20080607 0.76
SCHEMBL20049944 0.74
SCHEMBL18542552 0.72
SCHEMBL13135700 0.72
SCHEMBL8461479 0.71 TRIM24 (0.38) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020247872-A1 T-CELL DEPLETING THERAPIES Magenta Therapeutics, Inc. (US) 2020-12-10 WO disclosed
EP-3443958-A1 IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS Incyte Holdings Corporation (US) 2019-02-20 EP disclosed